The Consolidated Appropriations Act, a bill signed into law in December of 2022, contains the FDA Omnibus Reform Act of 2022 (FDORA), an act that will impact clinical research in many ways from decentralized trial guidance and digital health technologies guidance to BIMO inspection updates and changes to the accelerated approval process.
Article